Lisa Caperelli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lisa caperelli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lisa Caperelli Today - Breaking & Trending Today

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Third Quarter Corporate and Financial Update Conference Call. ....

City Of , United Kingdom , David Hastings , Dave Hastings , Mike Mcelhaugh , Bristol Myers Squibb , Michaelj Mcelhaugh , Roy Buchanan , Karen Sims , Lisa Caperelli , Arbutus Biopharma Corp , Arbutus Biopharma Corporation , Call Transcript November , Biopharma Corporation , Arbutus Third Quarter Corporate , Financial Update Conference , Bill Collier , Chief Executive Officer , Chief Financial Officer , Chief Operating Officer , Mike Sofia , Chief Scientific Officer , Chief Medical , Liver Meeting , Barinthus Bio Therapeutics , Chief Operating ,

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call. [Operator Instructions] Please be advised that today s conference is being recorded. ....

New Zealand , David Hastings , Lisa Caperelli , Mike Mack , Karen Sims , Dave Hastings , Market Offering Program , Arbutus Biopharma Corp , Arbutus Biopharma Corporation , Call Transcript August , Biopharma Corporation , Bill Collier , Chief Executive Officer , Chief Financial Officer , Mike Sofia , Chief Scientific Officer , Chief Medical , Market Offering , Healthy Subject Single Ascending Dose , Tech Stocks , Best Healthcare , Dennis Ding ,

Arbutus Presents Preliminary AB-729 and Pegylated Interferon Alfa-2a Combination Data at the EASL Congress 2023

Treatment was generally well tolerated with continued HBsAg declines in some patients WARMINSTER, Pa., June 21, 2023 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company. | June 21, 2023 ....

United States , N Acetylgalactosamine Galnac , Lisa Caperelli , William Collier , World Health Organization , Arbutus Biopharma Corporation Nasdaq , Securities Exchange , Biopharma Corporation , European Association , Chief Executive Officer , Looking Statements , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports , Investor Relations ,

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2022 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Conference Call. ....

David Hastings , William Collier , Dave Hastings , Lisa Caperelli , Brian Skorney , Charles Moore , Mike Mc , Michael Mcelhaugh , Qilu Pharmaceutical Company , Arbutus Biopharma Corp , Arbutus Biopharma Corporation , National Cancer Institute On Unsplash , Health Photo , Arbutus Biopharma Corporation Fourth Quarter , Call Transcript March , Corporate Update Conference , Arbutu Fourth Quarter , Corporate Update , Arbutus Executive , Bill Collier , Chief Executive Officer , Chief Financial Officer , Mike Sofia , Chief Scientific , National Cancer Institute , Greater China ,

Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript

ABUS earnings call for the period ending June 30, 2022. ....

Gaston Picchio , Qa Gaston Picchio , David Hastings , Dave Hastings , Lisa Caperelli , Arbutus Biopharma , Bill Collier , Mike Sofia ,